Analysis of the Estrogen Receptor α cofactors with reference to Hormone Dependency of Breast Cancer
Analysis of the Estrogen Receptor α cofactors with reference to Hormone Dependency of Breast Cancer
批准号:
11671176
负责人:
IWASE Hirotaka
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
1.雌激素受体α(ER-α)在乳腺癌细胞中的转录调控AIB1的ERα转录活性高于SRC-1、PCAF和CARM1。结论1.AIB1是SRC-1核受体共激活子家族的成员,它与类固醇激素受体相互作用,增强配体依赖的方式。AIB1在乳腺癌中的基因扩增我们用1.27kb的cDNA探针对124例原发乳腺癌DNA进行了EcoRI酶切和Southern杂交分析。在124个乳腺肿瘤中,有2个(1.6%)出现了扩增。例1的扩增水平为3倍。例2杂交条带上移,扩增水平为5倍。这种扩增很少见,被认为对乳腺癌的荷尔蒙发育并不重要。AIB1 OVER…应用免疫组织化学方法检测115例乳腺癌组织中AIB1蛋白的表达。阳性染色见于胞核、胞浆及两者。以核染色为阳性时,阳性率为16%(18/115)。AIB1阳性与ERα状态相关(P=0.021)。在接受内分泌治疗的患者中,AIB1阳性、ER阳性的5例患者中,4例对内分泌治疗有效,而16例AIB1阴性、ER阳性的患者中,仅4例有效(P=0.047)。这意味着AIB1的核表达被认为是乳腺癌内分泌治疗的预测因子。乳腺癌组织中野生型ERβ表达的临床意义88例乳腺癌中有52例ERβ表达阳性(59%)。ERβ染色与ERα状态相关(P=0.0 2)。ER-β阳性患者的无瘤生存率明显高于ER-DNA阴性患者(LOGRANK检验:P=0.017)。我们的数据表明,野生型ERβ蛋白的表达可以作为乳腺癌的良好预后指标。较少
英文摘要
1. Transcriptional regulation of the estrogen receptor α(ERα) in breast cancer cell linesWe analyzed the transcriptional activity of the various kinds ERα cofactors, such as SRC-1, AIB1, PCAF, and CARM1 using TATA luciferase assay in the transformed COS7 cells. The ER α transcriptional activity of AIB1 was stronger than those of SRC-1, PCAF, and CARM1. AIB1 is a member of the SRC-1 family nuclear receptor coactivators, which interact with steroid hormone receptors to enhance ligand-dependent manner.2. Gene amplification of AIB1 in breast cancerWe analyzed 124 primary breast cancer DNAs digested with EcoRI and immobilized on Southern blotting membranes with a 1.27-kb cDNA probe. Amplification was observed in two of 124(1.6%)breast tumors. Amplification level of case 1 was 3-fold. Hybridization band of case 2 was upper-shifted and its amplification level was 5-fold. This amplification was qite rare and was thought to be unimportant for the hormonal development of breast cancer.3. AIB1 ov … More erexpression in breast cancerWe performed immunohistochemical detection of AIB1 protein in 115 cases with breast cancer. The positive staining was showed in the nucleus, cytoplasm and both of them. When the nuclear staining was evaluate as positive, the positive rate was 16%(18/115). The positivity of AIB1 was correlated with ER α status(P=0.021). In the patents treated by endocrine therapy, 4 of 5 patient with positive AIB1 and positive ER were responsive for endocrine therapy, whereas only 4 of 16 patients with negative AIB1 and positive ER were responsive(P=0.047). This means that the nuclear expression of AIB1 was thought to be predictive factors for endocrine therapy in breast cancer.4. Clinical value of the wild-type ER β expression in breast cancer.ER β positive staining was seen in 52(59%)of 88 breast cancers. ER β staining was correlated with ER α status(P=0.02). ER β positive cases showed a better prognosis than negative cases in disease -free survival rate(Logrank test : P=0.017). Our data demonstrated the possibility that the wild-type ERβ protein expression could be used as a good prognostic indicator for breast cancer. Less
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
岩瀬弘敬: "エストロゲンレセプターの分子機構とホルモン依存性"乳癌の臨床. 15巻5号. 490-496 (2000)
Hirotaka Iwase:“雌激素受体的分子机制和激素依赖性”临床乳腺癌,第 15 卷,第 5 期。490-496 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
岩瀬弘敬: "エストロゲンレセプターの分子機構とホルモン依存性"乳癌の臨床. 15巻・5号. 490-496 (2000)
Hirotaka Iwase:“雌激素受体的分子机制和激素依赖性”临床乳腺癌,第 15 卷,第 5 期。490-496 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Omoto Y, Iwase H et al.: "Clinical value of the wild-type estrogen receptor β expression in breast cancer"Cancer Letters. 163. 207-212 (2001)
Omoto Y、Iwase H 等:“乳腺癌中野生型雌激素受体 β 表达的临床价值”Cancer Letters 163. 207-212 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirotaka Iwase, et al: "Molecular mechanism of the estrogen receptor and hormone dependency"Jpn J Breast Cancer. 15(5). 490-496 (2000)
Hirotaka Iwase 等:“雌激素受体和激素依赖性的分子机制”Jpn J Breast Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Omoto Y, Iwase H, et al: "Clinical value of the estrogen receptor β expression in breast cancer"Cancer Letters. 163. 207-212 (2001)
Omoto Y、Iwase H 等人:“乳腺癌中雌激素受体 β 表达的临床价值”Cancer Letters 163. 207-212 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Development of quantitative evaluation tool using multigene expression to predict efficacy of endocrine therapy for breast cancer
-
批准号:24591910
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:IWASE Hirotaka
-
依托单位:
The study on the sensitization of transcriptional modulator to endocrine therapy for breast cancer
-
批准号:19591513
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:IWASE Hirotaka
-
依托单位:
Clinicopathological and Functional Analysis of Hormone Related Gene in Breast Cancer
-
批准号:14370362
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.21万
-
财政年份:2002
-
负责人:IWASE Hirotaka
-
依托单位:
Role of ATBF1 gene in carcinogenesis and progression in breast cancer
-
批准号:09671241
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:IWASE Hirotaka
-
依托单位:
海外基金